lobbying_activities: 745031

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
745031	6312a200-1e5a-4c5d-805f-eb8115463119	Q1	MEHLMAN CONSULTING, INC.	284950	FOREST LABORATORIES INC	2009	first_quarter	GOV	Health reform and related health care issues, including potential changes to Medicaid rebate. Tax policy (repatriation). S.525, The Pharmaceutical Market Access and Drug Safety Act of 2009.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2009-04-06T15:58:15-04:00